It’s no secret that South Korea is currently a hot bed for clinical trials. This market has been flagged as a solid investment opportunity for the future and early results have not disappointed.
We reached out to some industry players active on the Korean pharma scene today to gain their insights on what they think contributes to the success of this market and their predictions for the future.
This ebook features contributions from:
- Kangstem biotech
- Dong-A University Hospital
All the contributors featured in this Ebook will be present at the BioPharma Korea Convention 2014 taking place in October this year. Visit the website for further information about this event.
I hope you find these interviews both informative and insightful.